Skip to content

A clinical study to see the effect of some Ayurvedic formulation in the treatment of headache which involves pain at eye, eyebrow, forehead,etc

Clinical Trial To Evaluate The Efficacy Of Bhringaraja Swarasadi Siddha Taila Nasya In The Management Of Suryavarta.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040324
Enrollment
40
Registered
2022-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with the clinical features of Suryavarta like headache increases in mid-day, pain at Akshi (eye region), Bhru (eyebrow region), Lalata (forehead) and Sankha Pradesh (temporal region). 2. The age group between 18 years to 60 years. 3. Patients of any gender, economic status, religion, occupation. 4. Patient eligible for Nasya karma.

Exclusion criteria

Exclusion criteria: 1. Patient having any systemic/ chronic illness like hypertension, diabetes. 2. Pregnant and lactating women 3. Headache due to neurological pathologies like tumor, etc. 4. Patient suffering from Dushta Pratishaya.

Design outcomes

Primary

MeasureTime frame
Symptoms like pain at Akshi(region of eye), Bhru( eye brows), Sankha(temporal region) and Lalata Pradesh (forehead) will be decreased, subject will get relief from suryavartaTimepoint: Follow up will be taken on 4th, 7th, 14th, 21st day. Symptoms will be noted of before and after treatment.

Secondary

MeasureTime frame
Decrease in severity, duration of pain.Timepoint: 18 months

Countries

India

Contacts

Public ContactPROF DR MRS NILAKSHI S PRADHAN

Mams Sumatibhai Shah Ayurved Mahavidhyalay, Hadapsar, Pune

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026